Frontiers An overview of agents and treatments for PDGFRA

lt;p>Platelet-derived growth factor receptor A (PDGFRA) mutations occur in approximately 10–15% of gastrointestinal stromal tumors (GISTs). These tumors with P

Frontiers An overview of agents and treatments for PDGFRA-mutated gastrointestinal stromal tumors

Frontiers Insights Into the Role of Platelet-Derived Growth Factors: Implications for Parkinson's Disease Pathogenesis and Treatment

Frontiers Case Report: Evolution of KIT D816V-Positive Systemic Mastocytosis to Myeloid Neoplasm With PDGFRA Rearrangement Responsive to Imatinib

Schematic representation of KIT and PDGFRA mutations found in GISTs.

A precision therapy against cancers driven by KIT/PDGFRA mutations

Platelet-derived growth factor alpha (PDGFRA) D842V mutation is

Combination therapies and multi-target KIs are able to overcome

Full article: PDGF as an Important Initiator for Neurite Outgrowth Associated with Fibrovascular Membranes in Proliferative Diabetic Retinopathy

Frontiers Noncoding RNAs in Drug Resistance of Gastrointestinal Stromal Tumor